Sep 25
Smallcap holds up to 12 small caps above $200M trading at $1 or more. Selection follows the model's conviction in each name.
Equal capital goes into every recommendation. Recommendations are published a few hours before the open and placed as market orders, so buys and sells fill at the opening price. There is no maximum holding period: a position exits when the model no longer selects it or when the stop is hit. Every position carries a 25% stop-loss: if the price touches it during the day, the position is sold there, at 75% of its entry price. Reported returns are measured from those opening prices and include every stop-loss exit.
The company will host its CONNECT 2026 event in San Francisco on October 15–16, 2026. This event is expected to feature public demonstrations of the newly announced Exensio Aurora technology, serving as a potential catalyst for investor interest.
PDF Solutions Press ReleaseOmniAb will host an Investor & Analyst Day at its headquarters in Emeryville, California. The event will feature presentations from the executive leadership team covering corporate updates, partner programs, the xPloration platform, and technology innovations, followed by a Q&A session and laboratory tours.
Business WireThe Centers for Medicare & Medicaid Services (CMS) has granted a New Technology Add-on Payment (NTAP) of up to $2,171 per eligible Medicare inpatient case for the Ceribell Delirium Monitor System. This reimbursement, effective October 1, 2026, is expected to drive adoption and revenue growth for the company's delirium monitoring solution.
StockTitanAlpha Teknova is scheduled to participate in the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026. Such events often provide a platform for management to update investors on business progress and strategic initiatives.
Alpha Teknova Investor RelationsThe company is approaching the expected readout for its Phase 3 clinical trial of COMP360 psilocybin treatment for treatment-resistant depression. As this is the primary value driver for the company, the market is highly sensitive to the timing and outcome of these results, which are expected in the near term.
Compass Pathways Investor RelationsSeanergy Maritime declared a quarterly dividend of $0.35 per share, with an ex-dividend date of September 25, 2026, and a payment date of October 9, 2026. This represents a significant increase from the previous $0.20 dividend, reflecting strong cash generation and a commitment to shareholder returns.
MarketBeatInvestors are reacting to a proposed 2027 Medicare lab rate update that could reduce reimbursement by up to 15% for several key tests. This potential regulatory change threatens future revenue and margins, contributing to recent stock price volatility and downward pressure.
TipRanksAmerican Outdoor Brands was upgraded to a Zacks Rank
ZacksB. Riley Securities increased its price target for Strive from $26 to $33 while maintaining a Buy rating. This analyst action reflects growing institutional confidence in the company's Bitcoin treasury model and its positioning as a beneficiary of potential regulatory shifts.
MarketBeatFollowing investor meetings with management, BTIG reiterated a Buy rating and $30 price target for CBLL. The firm highlighted confidence in the company's growth drivers, including the Veterans Affairs expansion and the upcoming delirium launch, as well as a strong gross margin profile.
Investing.comStrive disclosed the purchase of 1,355 Bitcoin for approximately $107.7 million, bringing its total treasury holdings to 26,355 BTC. This ongoing accumulation strategy is a primary driver of the stock's performance and market narrative as a high-beta Bitcoin proxy.
Strive.comREX Shares and Tuttle Capital launched the ASSX ETF, which provides 2x leveraged exposure to Strive's daily performance. The introduction of this financial product has increased trading interest and volatility in ASST shares by deepening market exposure.
Business WireFollowing the company's Q2 2026 earnings report and raised revenue guidance, multiple analysts have maintained or reiterated "Strong Buy" ratings. The consensus reflects optimism regarding the company's growth trajectory and progress toward profitability.
Public.comJefferies initiated coverage of Alpha Teknova on September 17, 2026, with a Buy recommendation. This analyst action serves as a positive signal for institutional investor sentiment.
NasdaqSenior management participated in the Morgan Stanley 24th Annual Global Healthcare Conference on September 16, 2026, including a fireside chat. This event provided a platform for management to discuss commercial momentum and the company's path to cash flow breakeven, reinforcing positive investor sentiment.
Avita Medical Press ReleaseAlpha Teknova introduced the Fill-Tek Dispensing System on September 16, 2026, a proprietary technology for single-use bag filling. The system is designed to improve manufacturing flexibility and efficiency, potentially enhancing the company's competitive position in the biopharmaceutical reagent market.
Alpha Teknova Press ReleaseMultiple executives, including the CEO and CFO, reported selling shares of common stock in mid-September 2026. These transactions were executed pursuant to pre-arranged Rule 10b5-1 trading plans, which are typically used to sell shares systematically rather than based on non-public information.
StockTitanPDF Solutions unveiled Exensio Aurora, a new analytics architecture designed for petabyte-scale semiconductor manufacturing data and agentic AI. The platform is entering a beta release phase in September 2026, with public demonstrations scheduled for the company's CONNECT 2026 event in October.
PDF Solutions Press ReleaseEton Pharmaceuticals is scheduled to begin commercialization of the FDA-approved orphan drug IMPAVIDO in September 2026. This launch is a key component of the company's 2026 growth strategy and revenue expansion.
Eton Pharmaceuticals Press ReleaseRecent SEC filings indicate substantial selling of company shares by insiders, including the CEO, throughout August 2026. Such high-volume selling by management can sometimes signal a lack of confidence in further short-term upside or profit-taking after a significant stock rally.
Benzinga